Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,961 total articles
Meta's multi-year AI investment is expensive, but the company now has a credible pathway to monetize a ~3.6 billion user base with AI-driven ads and experiences. Recent weakness has left the stock attractively priced relative to the upside from AI-enabled product improvements. This trade idea lays out an actionable long with entry, stop, and target…
Sanofi is trading at $43.26 with a $103.1B market capitalization, a 4.11% yield, and recent top-line momentum led by Dupixent. Q2 showed 17.8% constant-currency sales growth and management upgraded 2026 guidance. The stock’s valuation, current technicals and modest short interest create an asymmetric long opportunity for investors willing to hold t…
Alphabet combines a dominant ad/search franchise with fast-growing cloud AI demand and a pristine balance sheet. At ~$364.59 the stock trades at a mid-teens P/E with meaningful free cash flow and margin optionality. This trade idea lays out a concrete entry, stop and target for a long-term (180 trading days) position and the catalysts and risks to …
First Solar (FSLR) combines industry-leading module technology with strong free cash flow, no meaningful debt, and a mid-teens P/E. The stock pulled back into the $225-$240 area after recent volatility. For investors willing to own a high-conviction solar name through policy and project execution noise, this offers an attractive risk-reward: enter …
Rocket Lab has shifted decisively from a pure-play commercial launcher to a vertically integrated space and defense company. Recent contract wins totaling hundreds of millions, a growing backlog and a strategic Iridium acquisition create a path to 2027 profitability. The valuation is rich, but the balance sheet, contract cadence and a clear go-to-m…
Palantir’s Q2 blowout and follow-through rally have combined fundamental acceleration and technical confirmation. Despite steep multiples, revenue growth, FCF generation and improving breadth make a mid-term long trade attractive. Entry at $160, stop at $140, target $200 with a 45 trading-day horizon.
Amkor (AMKR) has been a direct beneficiary of the AI-driven bump in packaging and test demand but still trades at reasonable multiples. The company's $1.69B Q1 revenue beat, optimistic Q2 guidance, and a 10-year capacity partnership with TSMC argue for upside. I present a swing trade plan to capture re-rating into $75 while keeping a disciplined st…
Zeta Global's revenue acceleration and sizable free cash flow have finally begun to show up at the bottom line. With a visible partnership pipeline and recurring revenue tailwinds, the stock looks tradeable on a mid-term horizon. This plan defines an entry, stop and target while laying out catalysts and the key risks that would invalidate the setup…
The market appears fixated on short-term launch and regulatory headlines while underweighting recurring revenue potential and margin leverage in Starlink plus strategic optionality from Starship commercialization. This trade idea buys that disconnect: enter at $250.00, target $350.00, stop $200.00 over a 180-trading-day horizon.
Palantir's accelerating AIP adoption and clearer path to higher-margin revenue have convinced me to raise my target to $38. This is a tactical long for patient, risk-aware traders: entry at $25.00, stop at $21.00, target at $38.00 over a long-term (180 trading days) horizon.
ASML has been punished recently on headlines about a Chinese DUV vendor and an AI sector pullback. Fundamentals and capacity math still favor ASML's EUV franchise. This is a tactical long: enter on the dip, size for a mid-term (45 trading days) swing, protect with a tight stop and take profits into a known resistance band near $1,900.
ON Semiconductor's $7 billion Synaptics acquisition and management's synergy roadmap materially change the company's growth profile. With free cash flow of $1.5B, an EPS of $2.65 and a reasonable balance sheet, I am raising my price target to reflect a re-rated multiple for physical-AI exposure. This is an actionable idea: buy near $76.50, target $…
BrainsWay (BWAY) is a niche leader in Deep Transcranial Magnetic Stimulation (Deep TMS) with recent regulatory wins and research grants that support adoption. With a ~$608M market cap and a compact workforce, the company can grow clinic penetration without heavy capex. This trade idea takes a mid-term bullish stance into Q2 results and potential co…
Palantir crushed Q2, sent the stock up 27% and left momentum high but valuation very rich. This trade idea lays out a disciplined long entry after the post-earnings rally, with exact entry, stop and target, plus the fundamental and technical reasoning that justifies a mid-term swing trade.
Rigel is no longer just a clinical-stage story. With an FDA-approved oral PROTAC (VEPPANU) and an established hematology product (Tavalisse), the company sits at an attractive valuation (market cap ~$775M) with near-term commercial catalysts and demonstrated free cash flow. This trade buys a pullback into technical support and positions for revenue…
SCHD (Schwab US Dividend Equity ETF) offers 3%+ yield, a low cost structure and exposure to 100 high-quality dividend payers. With bullish technicals and a recent stretch of outperformance, a mid-term long trade sized to limit downside and capture income plus rally upside is an actionable way to reduce portfolio volatility in a risky market environ…
Miami International (MIAX) looks like a growth exchange still in the early innings of network effects. Rising liquidity, a debt-free balance sheet and expanding product mix support continued upside. I upgrade MIAX to a mid-term long trade with clear entry, stop and target levels.
GEMI's collapse from its IPO highs priced in a lot of bad news. With market cap near $0.5B, an enterprise value under $400M and heavy short interest, the stock is priced for failure. A disciplined long entry at $4.05 with a $3.70 stop and a $6.50 target offers asymmetric upside if the company can stabilize operations, provide clearer guidance on it…
Pinterest is trading well below its 52-week high after a year of advertising bounces and founder liquidity events. The stock offers $1.2B in free cash flow, an enterprise value near $14.9B and a valuation that looks reasonable versus its cash-generation profile. This trade targets a rebound to $30 over a multi-month position while protecting downsi…
Broadcom has faced near-term noise from compute-cycle weakness, but a structural shift toward optical interconnects across cloud, AI, and networking should drive durable revenue leverage. This trade idea upgrades Broadcom to a long stance. Entry $1000.00, target $1300.00, stop $850.00. Time horizon: long term (180 trading days).
SoFi reported a strong Q2 with $1.2B in revenue (up ~43% YoY), massive tangible book growth and improving cross-sell, but the stock dropped after management held adjusted EBITDA and EPS guidance. The fundamentals argue this is a durable fintech franchise; the market’s reaction opens a swing trade with asymmetric upside if cross-sell momentum contin…
NGL Energy Partners has turned its Water Solutions segment into a high-margin growth engine. With $660M adjusted EBITDA in 2026, a completed $950M refinancing, and management guidance of $715-$725M for 2027, the setup favors a re-rate. This trade targets share-price recovery and multiple expansion while respecting balance-sheet risk.
Enel's share price is carving higher on steady fundamentals and constructive technicals. With a market cap of $117.6B, a 2.42% yield and a P/E of 24.4, the stock looks positioned to continue a grid-led re-rating. This trade targets further upside while protecting capital on a defined stop.
Palantir reported $1.9B in Q2 revenue (93% YoY) and raised FY guidance to roughly $8.15B, signaling that enterprise AI adoption is accelerating beyond government work. The stock is richly valued, but momentum, improving fundamentals, and a still-small commercial AI penetration argue for a targeted long trade over the next 180 trading days with a st…
Freshworks is showing durable multi-product sales strength, positive cash flow, and improving profitability while trading at a reasonable multiple for a software company. We like a risk-defined long trade at current levels ($11.50) targeting a re-rating to $16.00 over a 180 trading-day horizon, with a stop at $9.75.
